North America Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030

The North America Theranostics Market would witness market growth of 14.6% CAGR during the forecast period (2023-2030).

The US market dominated the North America Theranostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,621.7 million by 2030. The Canada market is experiencing a CAGR of 17.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 16.1% during (2023 - 2030).

Theranostic, a portmanteau of “therapeutics” and “diagnostics,” represents a convergence of diagnostic imaging, molecular diagnostics, and targeted therapies, enabling personalized and precision medicine approaches tailored to individual patient characteristics. Diagnostic imaging modalities such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) provide detailed anatomical and functional information, allowing for the visualization and characterization of disease processes.

Theranostic approaches are used for cancer diagnosis, staging, treatment selection, and monitoring. Diagnostic imaging modalities such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) coupled with molecular imaging agents enable accurate localization and characterization of tumours. Molecular diagnostics, including next-generation sequencing (NGS) and polymerase chain reaction (PCR), identify genetic mutations, biomarkers, and molecular signatures associated with specific cancer types, guiding treatment decisions.

The prevalence of cancer in Canada underscores the importance of precision medicine approaches in cancer care. These allow personalized treatment strategies tailored to individual patients based on their tumor characteristics, genetic makeup, and treatment responses. According to the Canadian Cancer Society, researchers estimated that there were 239,100 new cancer cases and 86,700 cancer deaths in Canada in 2023. Hence, the high cancer incidence is propelling the region’s market growth.

Free Valuable Insights: The Theranostics Market is Predict to reach USD 5.4 Billion by 2030, at a CAGR of 15.2%

Based on End User, the market is segmented into Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers. Based on Product, the market is segmented into Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services. Based on Application, the market is segmented into Prostate Cancer, Bone Metastasis, Other Cancers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Bayer AG
• GE HealthCare Technologies, Inc.
• Siemens Healthineers AG (Siemens AG)
• Cardinal Health, Inc.
• Canon, Inc.
• Clarity Pharmaceuticals Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific, Inc.
• Telix Pharmaceuticals Limited
• ABX advanced biochemical compounds GmbH

North America Theranostics Market Report Segmentation

By End User

• Hospitals & Cancer Care Centers
• Theranostics Centers
• Research & Academic Centers

By Product

• Radiopharmaceuticals
• Diagnostic Imaging
• IVD/Biomarker Screening
• Software & Services

By Application

• Prostate Cancer
• Bone Metastasis
• Other Cancers
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Theranostics Market, by End User
1.4.2 North America Theranostics Market, by Product
1.4.3 North America Theranostics Market, by Application
1.4.4 North America Theranostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. North America Theranostics Market by End User
4.1 North America Hospitals & Cancer Care Centers Market by Country
4.2 North America Theranostics Centers Market by Country
4.3 North America Research & Academic Centers Market by Country

Chapter 5. North America Theranostics Market by Product
5.1 North America Radiopharmaceuticals Market by Country
5.2 North America Diagnostic Imaging Market by Country
5.3 North America IVD/Biomarker Screening Market by Country
5.4 North America Software & Services Market by Country

Chapter 6. North America Theranostics Market by Application
6.1 North America Prostate Cancer Market by Country
6.2 North America Bone Metastasis Market by Country
6.3 North America Other Cancers Market by Country
6.4 North America Others Market by Country

Chapter 7. North America Theranostics Market by Country
7.1 US Theranostics Market
7.1.1 US Theranostics Market by End User
7.1.2 US Theranostics Market by Product
7.1.3 US Theranostics Market by Application
7.2 Canada Theranostics Market
7.2.1 Canada Theranostics Market by End User
7.2.2 Canada Theranostics Market by Product
7.2.3 Canada Theranostics Market by Application
7.3 Mexico Theranostics Market
7.3.1 Mexico Theranostics Market by End User
7.3.2 Mexico Theranostics Market by Product
7.3.3 Mexico Theranostics Market by Application
7.4 Rest of North America Theranostics Market
7.4.1 Rest of North America Theranostics Market by End User
7.4.2 Rest of North America Theranostics Market by Product
7.4.3 Rest of North America Theranostics Market by Application

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 GE HealthCare Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Siemens Healthineers AG (Siemens AG)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Cardinal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Clarity Pharmaceuticals Ltd
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Telix Pharmaceuticals Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. ABX advanced biochemical compounds GmbH
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 North America Theranostics Market, 2019 - 2022, USD Million
TABLE 2 North America Theranostics Market, 2023 - 2030, USD Million
TABLE 3 North America Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 4 North America Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 5 North America Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 12 North America Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 13 North America Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 17 North America IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 18 North America IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 22 North America Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 23 North America Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 33 US Theranostics Market, 2019 - 2022, USD Million
TABLE 34 US Theranostics Market, 2023 - 2030, USD Million
TABLE 35 US Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 36 US Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 37 US Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 38 US Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 39 US Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 40 US Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 41 Canada Theranostics Market, 2019 - 2022, USD Million
TABLE 42 Canada Theranostics Market, 2023 - 2030, USD Million
TABLE 43 Canada Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 44 Canada Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 45 Canada Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 46 Canada Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 47 Canada Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 48 Canada Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 49 Mexico Theranostics Market, 2019 - 2022, USD Million
TABLE 50 Mexico Theranostics Market, 2023 - 2030, USD Million
TABLE 51 Mexico Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 52 Mexico Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 53 Mexico Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 54 Mexico Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 55 Mexico Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 56 Mexico Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 57 Rest of North America Theranostics Market, 2019 - 2022, USD Million
TABLE 58 Rest of North America Theranostics Market, 2023 - 2030, USD Million
TABLE 59 Rest of North America Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 60 Rest of North America Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 61 Rest of North America Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 62 Rest of North America Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 63 Rest of North America Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 64 Rest of North America Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 65 Key Information – Bayer AG
TABLE 66 Key Information – GE HealthCare Technologies, Inc.
TABLE 67 Key Information – Siemens Healthineers AG
TABLE 68 key information – Cardinal Health, Inc.
TABLE 69 Key Information – Canon, Inc.
TABLE 70 Key Information – Clarity Pharmaceuticals Ltd
TABLE 71 Key Information – Koninklijke Philips N.V.
TABLE 72 Key Information – Thermo Fisher Scientific, Inc.
TABLE 73 Key Information – Telix Pharmaceuticals Limited
TABLE 74 Key Information – ABX advanced biochemical compounds GmbH

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Theranostics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Theranostics Market
FIG 4 Porter’s Five Forces Analysis - Theranostics Market
FIG 5 North America Theranostics Market share by End User, 2022
FIG 6 North America Theranostics Market share by End User, 2030
FIG 7 North America Theranostics Market by End User, 2019 - 2030, USD Million
FIG 8 North America Theranostics Market share by Product, 2022
FIG 9 North America Theranostics Market share by Product, 2030
FIG 10 North America Theranostics Market by Product, 2019 - 2030, USD Million
FIG 11 North America Theranostics Market share by Application, 2022
FIG 12 North America Theranostics Market share by Application, 2030
FIG 13 North America Theranostics Market by Application, 2019 - 2030, USD Million
FIG 14 North America Theranostics Market share by Country, 2022
FIG 15 North America Theranostics Market share by Country, 2030
FIG 16 North America Theranostics Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Bayer AG
FIG 18 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 19 SWOT Analysis: Siemens Healthineers AG
FIG 20 Swot Analysis: Cardinal Health, Inc.
FIG 21 SWOT Analysis: CANON, INC.
FIG 22 SWOT Analysis: Clarity Pharmaceuticals Ltd
FIG 23 SWOT Analysis: Koninklijke Philips N.V.
FIG 24 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 25 SWOT Analysis: TELIX PHARMACEUTICALS LIMITED
FIG 26 SWOT Analysis: ABX advanced biochemical compounds GmbH